Business Units

The Sumitomo Pharma Group’s core business is its Pharmaceutical Business, but the Group is also active in other business areas including Frontier Business, which seeks to provide novel healthcare solutions other than pharmaceuticals.

In order to deliver innovative and useful pharmaceuticals to people of not just Japan but the world over, we are focusing our efforts on the research and development of new drugs, and at the same time, we proactively share information on our products in order to improve customer satisfaction. We are also active in other business areas where we can leverage the advanced technology and know-how we have accumulated through our pharmaceutical business.

Sumitomo Pharma’s value chain

Sumitomo’s value chain, including R&D, production/quality control, sales/marketing, regulatory compliance & quality assurance, medical science, as well as M&A and alliance.

Research

Clinical Development

Regulatory Compliance & Quality Assurance / Medical Science

Sales and Marketing

Regulatory Compliance & Quality Assurance / Medical Science

M&A and Alliance

Contribution to Societies Environment

Value Delivered to Society

  1. 1.By continually creating solutions, primarily in the form of innovative pharmaceuticals, we contribute to improving not just the treatments received by patients but also the QOL (quality of life) of patients and their families.
  2. 2.In addition to ensuring a stable supply of high-quality pharmaceuticals, we provide healthcare professionals as well as patients and their families with appropriate information to ensure the correct understanding of the proper use of our pharmaceutical products and the diseases they are indicated for.
  3. 3.We contribute to scientific advancement and pave the way to new possibilities in preventive as well as curative healthcare, by elucidating disease mechanisms and realizing new modalities such as regenerative medicine/cell therapy, through our research and development activities.
 

Research

We direct our research efforts to two priority disease areas (Psychiatry & Neurology and Oncology) and other areas.

 

Clinical Development

Leveraging our global development organization, we aim to secure early regulatory approvals by forming strategic clinical development plans and conducting clinical developments efficiently.

 

Production and Quality Control

We use strict quality controls to ensure the stable supply of our products.

 

Regulatory Compliance & Quality Assurance

We assure the quality of our products and product information at a global level throughout the lifecycle of our products, from the development stage through to post-marketing stage.

Medical Science

We create, provide, and disseminate information of high standard that is based on robust scientific evidence and meets medical needs.

 

Sales and Marketing

We provide healthcare professionals with information on the proper use of our pharmaceutical products, by building an information system which caters to changes in the market environment.

 

M&A and Alliance

In the interest of expanding our development pipeline, we are proactively pursuing opportunities for M&A, in-licensing, and alliance making, while also promoting alliances with external research institutions.

 

Contribution to Societies

We play our part in tackling social issues by listening to the requests and wishes of our stakeholders, and reflecting them in our business operations as well as CSR activities.

Environment

We recognize the responsibility we bear for our own environmental impact, and we are working to reduce our environmental impact across all business activities.